跳至主要内容
临床试验/NCT02337907
NCT02337907已完成2 期

A Multi-centre, Double-blind, Parallel-group, Randomised Controlled Study to Investigate Efficacy, Safety and Tolerability of Orally Administered BI 409306 During a 12-week Treatment Period Compared to Placebo in Patients With Cognitive Impairment Due to Alzheimer's Disease

Boehringer Ingelheim60 个研究点 分布在 10 个国家目标入组 329 人开始时间: 2015年1月21日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
329
试验地点
60
主要终点
Change From Baseline in Neuropsychological Test Battery in Total Z-score After 12-week Treatment.

研究概览

简要总结

The study is designed to compare the effects of BI 409306 compared to placebo in patients with cognitive impairment due to Alzheimer's Disease

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
55 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

BI 409306 dose 4

Experimental

干预措施: Placebo (Drug)

BI 409306 dose 4

Experimental

干预措施: BI 409306 (Drug)

Placebo comparator

Placebo Comparator

干预措施: Placebo (Drug)

BI 409306 dose 1

Experimental

干预措施: Placebo (Drug)

BI 409306 dose 1

Experimental

干预措施: BI 409306 (Drug)

BI 409306 dose 2

Experimental

干预措施: Placebo (Drug)

BI 409306 dose 2

Experimental

干预措施: BI 409306 (Drug)

BI 409306 dose 3

Experimental

干预措施: Placebo (Drug)

BI 409306 dose 3

Experimental

干预措施: BI 409306 (Drug)

Active Comparator Donepezil

Active Comparator

干预措施: Placebo (Drug)

Active Comparator Donepezil

Active Comparator

干预措施: Donepezil (Drug)

结局指标

主要结局

Change From Baseline in Neuropsychological Test Battery in Total Z-score After 12-week Treatment.

时间窗: Baseline and 12 weeks

Neuropsychological Test Battery (NTB) response, defined as change from baseline in total z-score after 12 weeks of treatment. The NTB consists of 9 validated components. Raw scores on each of the 9 NTB tests were converted to z-scores using the baseline means and standard deviations (SDs) for each test. The resultant z-scores were averaged to obtain a total z-score, incorporating all 9 NTB tests. The NTB Z-score indicates the number of standard deviations away from the mean. A Z-score of 0 is equal to the mean at baseline. Negative numbers indicate values lower than baseline and positive numbers indicate values higher than baseline. Least Squares Mean is actually an adjusted mean change from baseline.

Change From Baseline in Neuropsychological Test Battery in Total Z-score After 12-week Treatment From Two Sister Trials, Present 1289.5 (NCT02240693) and 1289.7 (NCT02337907)

时间窗: Baseline and 12 weeks

Neuropsychological Test Battery (NTB) response, defined as change from baseline in total z-score after 12 weeks of treatment. The NTB consists of 9 validated components. Raw scores on each of the 9 NTB tests were converted to z-scores using the baseline means and standard deviations (SDs) for each test. The resultant z-scores were averaged to obtain a total z-score, incorporating all 9 NTB tests. The NTB Z-score indicates the number of standard deviations away from the mean. A Z-score of 0 is equal to the mean at baseline. Negative numbers indicate values lower than baseline and positive numbers indicate values higher than baseline. The number of low test scores decreased with higher levels of intellectual abilities. Least Squares Mean is actually an adjusted mean change from baseline.

次要结局

  • Change From Baseline in Alzheimer's Disease Cooperative Study/Activities of Daily Living (ADCS-ADL) Total Score After 12-week Treatment(Baseline and 12 weeks)
  • Change From Baseline in Clinical Dementia Rating Scale Sum of Boxes (CDR-SB) Total Score After 12-week Treatment(Baseline and 12 weeks)
  • Change From Baseline in Alzheimer's Disease Assessment Scale-cognitive Subscale (ADAS-cog11) Total Score After 12-week Treatment(Baseline and 12 weeks)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (60)

Loading locations...

相似试验

BI 409306 in Patients With Cognitive Impairment Due... | 临床试验